L-Norleucinamide,N-(1-piperazinylcarbonyl)-L-phenylalanyl-N-[(1S)-1-(cyclohexylmethyl)-3,3-difluoro-4-(methylamino)-2,4-dioxobutyl]-(9CI) (121584-64-3)

Identification
Name:	L-Norleucinamide,N-(1-piperazinylcarbonyl)-L-phenylalanyl-N-[(1S)-1-(cyclohexylmethyl)-3,3-difluoro-4-(methylamino)-2,4-dioxobutyl]-(9CI)
Synonyms:	L-Norleucinamide,N-(1-piperazinylcarbonyl)-L-phenylalanyl-N-[1-(cyclohexylmethyl)-3,3-difluoro-4-(methylamino)-2,4-dioxobutyl]-,(S)-; CP 82218
CAS:	121584-64-3
Molecular Formula:	C32H48 F2 N6 O5
Molecular Structure:
Properties
Safety Data

Other Product

L-Norleucinamide,N-(4-morpholinylcarbonyl)-L-phenylalanyl-N-[(1S)-1-(cyclohexylmethyl)-3,3-difluoro-4-(methylamino)-2,4-dioxobutyl]-(9CI)
L-Norleucinamide,N-acetyl-L-phenylalanyl-N-[4-[(butylamino)carbonyl]-1-(cyclohexylmethyl)-2-hydroxy-5-methylhexyl]-,[1S-(1R*,2R*,4R*)]- (9CI)
Nα-[N-(Morpholinosulfonyl)-L-phenylalanyl]-N-[(1S)-1-(cyclohexylmethyl)-3,3-difluoro-4-[(2-morpholinoethyl)amino]-2,4-dioxobutyl]-4,5-didehydro-L-norvalinamide
L-Valinamide,N-(3-methyl-1-oxobutyl)-L-valyl-N-[3,3-difluoro-4-(methylamino)-1-(2-methylpropyl)-2,4-dioxobutyl]-,(S)- (9CI)
L-Cysteinamide,N-(4-morpholinylcarbonyl)-L-phenylalanyl-N-[(1S,2R)-1-(cyclohexylmethyl)-2-hydroxy-3-(1-methylethoxy)-3-oxopropyl]-S-methyl-
L-Cysteinamide,L-prolyl-4-iodo-L-phenylalanyl-N-[(1S,2R)-1-(cyclohexylmethyl)-2-hydroxy-3-(1-methylethoxy)-3-oxopropyl]-S-methyl-(9CI)
(2S)-N-[(1S)-1-(Cyclohexylmethyl)-3,3-difluoro-4-[(2-morpholinoethyl)amino]-2,4-dioxobutyl]-2-[[O-methyl-N-(morpholinosulfonyl)-L-tyrosyl]amino]-4-pentenamide
L-Alaninamide,N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-[(1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-(9CI)
L-Prolinamide,N-(4-methoxy-1,4-dioxobutyl)-L-phenylalanyl-L-alanyl-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-, (S)-
L-Prolinamide,N-(4-methoxy-1,4-dioxobutyl)-L-alanyl-L-alanyl-N-[(1S)-3-chloro-1-(1-methylethyl)-2-oxopropyl]-
L-Leucinamide,N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanyl-N-[(1S,2S,4R)-1-(cyclohexylmethyl)-2,5-dihydroxy-4-methylnonyl]-(9CI)
L-Prolinamide,N-(4-methoxy-1,4-dioxobutyl)-L-alanyl-L-alanyl-N-[(1S)-3-chloro-1-methyl-2-oxopropyl]-
L-Valinamide,N-(3-methyl-1-oxobutyl)-L-valyl-N-[(1S,2R)-3,3-difluoro-2-hydroxy-4-(methylamino)-1-(2-methylpropyl)-4-oxobutyl]-(9CI)
L-Cysteinamide,L-prolyl-L-phenylalanyl-N-[(1S,2R)-1-(cyclohexylmethyl)-2-hydroxy-3-(1-methylethoxy)-3-oxopropyl]-S-methyl-,monohydrochloride (9CI)
L-Histidinamide,N-[3-(3-hydroxy-4-iodophenyl)-1-oxopropyl]-L-phenylalanyl-N-[2-[[1-[(butylamino)carbonyl]-3-pentenyl]amino]-1-(cyclohexylmethyl)-2-hydroxyethyl]-,[1S-[1R*,2S*(R*)]]- (9CI)
L-Norleucinamide,N-[(1,1-dimethylethoxy)carbonyl]-D-phenylalanyl-L-alanyl-N-(4-nitrophenyl)-(9CI)
L-Histidinamide,N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanyl-N-[5-[(4-aminobutyl)amino]-1-(cyclohexylmethyl)-2-hydroxy-5-oxo-4-(4-pyridinylmethyl)pentyl]-,[1S-(1R*,2R*,4S*)]- (9CI)
L-Leucinamide,N-[4-[(aminoiminomethyl)amino]-1-oxobutyl]-L-phenylalanyl-N-[(1S,2R)-1-(cyclohexylmethyl)-2-hydroxy-2-(2-thiazolyl)ethyl]-(9CI)
L-Norleucinamide,L-arginyl-L-norleucyl-N-[4-(2-amino-2-oxoethyl)-2-oxo-2H-1-benzopyran-7-yl]-(9CI)
L-Arginine, compd with (1S-(1R*,2R*,4(R*(R*(R*)))))-N-(3-methyl-1-oxobutyl)-L-phenylalanyl-N-(4-((2-((1-(2-carboxy-1-hydroxyethyl)-3-methylbutyl)amino)-1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl)-L-norleucinamide (1:1)